| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-77234-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-41209-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-64849SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-71059 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-64358-0.2mg | |||
| BSA Free | NB100-64358-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-63062-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-64798-0.05mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70701 | |||
![Western Blot: BAFFR/TNFRSF13C Antibody [NBP1-77234] - Human (H), mouse (M), and rat (R) spleen tissue lysates with BAFF Receptor antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/BAFFR-TNFRSF13C-Antibody-Western-Blot-NBP1-77234-img0002.jpg "Western Blot: BAFFR/TNFRSF13C Antibody [NBP1-77234] - Human (H), mouse (M), and rat (R) spleen tissue lysates with BAFF Receptor antibody at 5 ug/ml.")
![Immunohistochemistry: BAFFR/TNFRSF13C Antibody - BSA Free [NBP1-77234] - Immunohistochemistry of BAFF Receptor in human tonsil tissue with BAFF Receptor antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/nbp1-77234_rabbit-polyclonal-baffr-tnfrsf13c-antibody-2711202420212393.jpg)
![Immunohistochemistry: BAFFR/TNFRSF13C Antibody - BSA Free [NBP1-77234] - Immunohistochemistry of BAFFR/TNFRSF13C in human spleen tissue with BAFFR/TNFRSF13C antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/nbp1-77234_rabbit-polyclonal-baffr-tnfrsf13c-antibody-2711202419241377.gif)
![Immunocytochemistry/ Immunofluorescence: BAFFR/TNFRSF13C Antibody - BSA Free [NBP1-77234] - Immunofluorescence of BAFFR/TNFRSF13C in human spleen tissue with BAFFR/TNFRSF13C antibody at 20 ug/ml.Red: BAFF Receptor Antibody Blue: DAPI staining](http://images.novusbio.com/fullsize/nbp1-77234_rabbit-polyclonal-baffr-tnfrsf13c-antibody-2711202420141949.gif)
![Western Blot: CCL2/MCP1 Antibody [NBP2-41209] - Analysis of CCL2 in K562 cell lysate with CCL2 antibody at 1 ug/mL.](http://images.novusbio.com/fullsize/CCL2-MCP1-Antibody-Western-Blot-NBP2-41209-img0005.jpg "Western Blot: CCL2/MCP1 Antibody [NBP2-41209] - Analysis of CCL2 in K562 cell lysate with CCL2 antibody at 1 ug/mL.")
![Immunohistochemistry: CCL2/MCP1 Antibody - BSA Free [NBP2-41209] - Immunohistochemistry of CCL2/MCP1 in human spleen tissue with CCL2/MCP1 antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/nbp2-41209_rabbit-polyclonal-ccl2-mcp1-antibody-2711202420414544.jpg)
![Immunocytochemistry/ Immunofluorescence: CCL2/MCP1 Antibody - BSA Free [NBP2-41209] - Immunofluorescence of CCL2/MCP1 in human spleen tissue with CCL2/MCP1 antibody at 20 ug/ml.](http://images.novusbio.com/fullsize/nbp2-41209_rabbit-polyclonal-ccl2-mcp1-antibody-27112024200419.jpg)
![ELISA: CTLA-4 Antibody (BNI3) [NB100-64849] - Human Anti-Abatacept Antibody bridging ELISA for Pharmacokinetic (PK) assay development A microtiter plate was coated overnight with Mouse Anti-Human CD152 Antibody, clone BNI3 at a concentration of 1 µg/ml. After washing and blocking with PBST + 5% BSA, 10% human serum was added spiked with increasing concentrations of abatacept. Detection was performed using HRP conjugated Human Anti-Abatacept Antibody, clone AbD37058ia at a concentration of 2 µg/ml in HISPEC Assay Diluent followed by QuantaBlu Fluorogenic Peroxidase Substrate. Data are shown as the mean of three measurements. HRP conjugation of the antibody used in this assay was performed using a LYNX Rapid HRP Antibody Conjugation Kit.](http://images.novusbio.com/fullsize/nb100-64849_mouse-monoclonal-ctla-4-antibody-bni3-2312025235988.jpg "ELISA: CTLA-4 Antibody (BNI3) [NB100-64849] - Human Anti-Abatacept Antibody bridging ELISA for Pharmacokinetic (PK) assay development A microtiter plate was coated overnight with Mouse Anti-Human CD152 Antibody, clone BNI3 at a concentration of 1 µg/ml. After washing and blocking with PBST + 5% BSA, 10% human serum was added spiked with increasing concentrations of abatacept. Detection was performed using HRP conjugated Human Anti-Abatacept Antibody, clone AbD37058ia at a concentration of 2 µg/ml in HISPEC Assay Diluent followed by QuantaBlu Fluorogenic Peroxidase Substrate. Data are shown as the mean of three measurements. HRP conjugation of the antibody used in this assay was performed using a LYNX Rapid HRP Antibody Conjugation Kit.")
![Western Blot: Jun Antibody (3G2) [NBP2-02258] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Jun (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-Jun.](http://images.novusbio.com/fullsize/Jun-Antibody-3G2-Western-Blot-NBP2-02258-img0004.jpg "Western Blot: Jun Antibody (3G2) [NBP2-02258] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Jun (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-Jun.")
![Immunocytochemistry/Immunofluorescence: Jun Antibody (3G2) [NBP2-02258] Staining of COS7 cells transiently transfected by pCMV6-ENTRY Jun.](http://images.novusbio.com/fullsize/Jun-Antibody-3G2-Immunocytochemistry-Immunofluorescence-NBP2-02258-img0005.jpg)
![Flow Cytometry: Jun Antibody (3G2) [NBP2-02258] - HEK293T cells transfected with either overexpression plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-Jun antibody, and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/Jun-Antibody-3G2-Flow-Cytometry-NBP2-02258-img0003.jpg)
![Flow Cytometry: Jun Antibody (3G2) [NBP2-02258] - Analysis of Hela cells, using anti-Jun antibody, (Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/Jun-Antibody-3G2-Flow-Cytometry-NBP2-02258-img0001.jpg)
![Flow Cytometry: Jun Antibody (3G2) [NBP2-02258] - Analysis of Jurkat cells, using anti-Jun antibody, (Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/Jun-Antibody-3G2-Flow-Cytometry-NBP2-02258-img0002.jpg)
![Western Blot: TCR gamma/delta Antibody (7A5) [NBP2-22510] - Analysis of 25 ug of CEM cell lysates.](http://images.novusbio.com/fullsize/TCR-gamma-delta-Antibody-7A5-Western-Blot-NBP2-22510-img0003.jpg "Western Blot: TCR gamma/delta Antibody (7A5) [NBP2-22510] - Analysis of 25 ug of CEM cell lysates.")
![Flow Cytometry: TCR gamma/delta Antibody (7A5) [NBP2-22510] - Analysis of TCR V gamma 9 in Jurkat cells (green) compared to an isotype control (blue).](http://images.novusbio.com/fullsize/TCR-gamma-delta-Antibody-7A5-Flow-Cytometry-NBP2-22510-img0002.jpg)
![Flow Cytometry: CD90/Thy1 Antibody (5E10) [NBP1-43379] - Analysis using the PerCP/Cy5.5 conjugate of NBP1-43379. Staining of the HEL cell line with Mouse IgG1 kappa Isotype Control PerCP-Cy5.5 (open histogram) or Anti-Human CD90 (Thy-1) PerCP-Cy5.5 (filled histogram). Total viable cells were used for analysis.](http://images.novusbio.com/fullsize/CD90-Thy1-Antibody-5E10-Flow-Cytometry-NBP1-43379-img0003.jpg "Flow Cytometry: CD90/Thy1 Antibody (5E10) [NBP1-43379] - Analysis using the PerCP/Cy5.5 conjugate of NBP1-43379. Staining of the HEL cell line with Mouse IgG1 kappa Isotype Control PerCP-Cy5.5 (open histogram) or Anti-Human CD90 (Thy-1) PerCP-Cy5.5 (filled histogram). Total viable cells were used for analysis.")
![Flow Cytometry: CD90/Thy1 Antibody (5E10) [NBP1-43379] - Staining of human erythroleukemia (HEL) cell line with 0.25 ug of Mouse IgG1 kappa Isotype Control Purified (NBP1-43319) (open histogram) or 0.25 ug of Anti-Human CD90 (Thy-1) Purified (filled histogram) followed by Anti-Mouse IgG FITC. Total viable cells were used for analysis.](http://images.novusbio.com/fullsize/CD90-Thy1-Antibody-5E10-Flow-Cytometry-NBP1-43379-img0001.jpg)
![Flow Cytometry: HLA DQ/DR/DP Antibody (WR18) [NB100-64358] - Staining of human peripheral blood lymphocytes.](http://images.novusbio.com/fullsize/HLA-DQ-DR-DP-Antibody-WR18-Flow-Cytometry-NB100-64358-img0001.jpg "Flow Cytometry: HLA DQ/DR/DP Antibody (WR18) [NB100-64358] - Staining of human peripheral blood lymphocytes.")
![CyTOF-ready: Lysozyme Antibody (BGN/0696/5B1) [NB100-63062] - Human bone marrow after RBC lysis was stained with surface antibodies, fixed, permeabilized with methanol, stained with anti-lysozyme NB100-63062, and gated for the above populations per Nat Med. 2020. 26:408-417. CyTOF image submitted by a verified customer review.](http://images.novusbio.com/fullsize/Lysozyme-Antibody-BGN-0696-5B1-CyTOF-ready-NB100-63062-img0001.jpg "CyTOF-ready: Lysozyme Antibody (BGN/0696/5B1) [NB100-63062] - Human bone marrow after RBC lysis was stained with surface antibodies, fixed, permeabilized with methanol, stained with anti-lysozyme NB100-63062, and gated for the above populations per Nat Med. 2020. 26:408-417. CyTOF image submitted by a verified customer review.")
![Immunocytochemistry/Immunofluorescence: IL-4 Antibody (BVD4-1D11) [NB100-64798] - Analysis of expression of IL-4 and IL-4 type II receptor subunits in undifferentiated mouse ESCs and mouse primary myoblasts. Representative images of immunocytochemistry analysis of IL-4Ralpha, IL-13Ralpha1, and IL-4 in mouse primary myoblasts at day 6 (white arrows indicate myoblasts, grey arrows indicate myotubes). Scale bar: 20 um. Image collected and cropped by CiteAb from the following publication (//www.mdpi.com/1422-0067/20/16/3932), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/IL-4-Antibody-BVD4-1D11-Immunocytochemistry-Immunofluorescence-NB100-64798-img0003.jpg "Immunocytochemistry/Immunofluorescence: IL-4 Antibody (BVD4-1D11) [NB100-64798] - Analysis of expression of IL-4 and IL-4 type II receptor subunits in undifferentiated mouse ESCs and mouse primary myoblasts. Representative images of immunocytochemistry analysis of IL-4Ralpha, IL-13Ralpha1, and IL-4 in mouse primary myoblasts at day 6 (white arrows indicate myoblasts, grey arrows indicate myotubes). Scale bar: 20 um. Image collected and cropped by CiteAb from the following publication (//www.mdpi.com/1422-0067/20/16/3932), licensed under a CC-BY license.")
![Immunocytochemistry/Immunofluorescence: IL-4 Antibody (BVD4-1D11) [NB100-64798] - Analysis of expression of IL-4 and IL-4 type II receptor subunits in undifferentiated mouse ESCs and mouse primary myoblasts. Representative images of immunocytochemistry analysis of IL-4Ralpha, IL-13Ralpha1, and IL-4 in undifferentiated ESCs. Scale bar: 20 um. Scale bar: 20 um. Image collected and cropped by CiteAb from the following publication (mdpi.com/1422-0067/20/16/3932), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/IL-4-Antibody-BVD4-1D11-Immunocytochemistry-Immunofluorescence-NB100-64798-img0004.jpg)
![Western Blot: IL-4 Antibody (BVD4-1D11) [NB100-64798] - Analysis of mouse IL-4 recombinant protein probed with RAT ANTI MOUSE INTERLEUKIN-4 followed by F(ab')2 RABBIT ANTI RAT IgG:HRP.](http://images.novusbio.com/fullsize/IL-4-Antibody-BVD4-1D11-Western-Blot-NB100-64798-img0002.jpg)
![Western Blot: LAT Antibody (LAT.10-17) [NBP2-00289] - 10e6 normal peripheral human blood cells (lane 1), Jurkat (lane 2), and C57BL/6 splenocytes (lane 3) with 5 ug/mL Anti-Human LAT Purified. Bands were visualized using Anti-Mouse IgG HRP.](http://images.novusbio.com/fullsize/LAT-Antibody-LAT-10-17-Western-Blot-NBP2-00289-img0001.jpg "Western Blot: LAT Antibody (LAT.10-17) [NBP2-00289] - 10e6 normal peripheral human blood cells (lane 1), Jurkat (lane 2), and C57BL/6 splenocytes (lane 3) with 5 ug/mL Anti-Human LAT Purified. Bands were visualized using Anti-Mouse IgG HRP.")
![Immunohistochemistry-Paraffin: LAT Antibody (LAT.10-17) [NBP2-00289] - Staining of human thymus. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 20 ug/ml.](http://images.novusbio.com/fullsize/LAT-Antibody-LAT-10-17-Immunohistochemistry-Paraffin-NBP2-00289-img0006.jpg)
![Flow (Cell Surface): LAT Antibody (LAT.10-17) [NBP2-00289] - Analysis using the Allophycocyanin conjugate of NBP2-00289. Surface staining of normal human peripheral blood cells with Anti-Human CD3 FITC followed by intracellular staining with Mouse IgG1 kappa Isotype Control APC (left) or Anti-Human LAT APC (right).](http://images.novusbio.com/fullsize/LAT-Antibody-LAT-10-17-Flow-Cell-Surface-NBP2-00289-img0008.jpg)
![Immunohistochemistry-Paraffin: LAT Antibody (LAT.10-17) [NBP2-00289] - Staining of human tonsil. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 20 ug/ml.](http://images.novusbio.com/fullsize/LAT-Antibody-LAT-10-17-Immunohistochemistry-Paraffin-NBP2-00289-img0005.jpg)
![Western Blot: CD23/Fc epsilon RII Antibody (OTI2B6) [NBP2-45624] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD23.](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-OTI2B6-Western-Blot-NBP2-45624-img0003.jpg "Western Blot: CD23/Fc epsilon RII Antibody (OTI2B6) [NBP2-45624] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD23.")
![Immunohistochemistry: CD23/Fc epsilon RII Antibody (OTI2B6) [NBP2-45624] - Analysis of Carcinoma of Human bladder tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-OTI2B6-Immunohistochemistry-NBP2-45624-img0002.jpg)
![Flow Cytometry: CD23/Fc epsilon RII Antibody (OTI2B6) [NBP2-45624] - analysis of living 293T cells transfected with FCER2 overexpression plasmid .](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-OTI2B6-Flow-Cytometry-NBP2-45624-img0004.jpg)
![Immunohistochemistry: CD23/Fc epsilon RII Antibody (OTI2B6) [NBP2-45624] - Analysis of Human lymphoma tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-OTI2B6-Immunohistochemistry-NBP2-45624-img0001.jpg)
![Flow Cytometry: CD23/Fc epsilon RII Antibody (OTI2B6) [NBP2-45624] - analysis of living RPMI-8226 cells, using anti-FCER2 antibody , compared to an isotype control (green), and a PBS control (blue) (1:100).](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-OTI2B6-Flow-Cytometry-NBP2-45624-img0005.jpg)